news
The University of Georgia and CEL-SCI Corporation have partnered to…
26 March 2020 | By Victoria Rees (Drug Target Review)
The University of Georgia and CEL-SCI Corporation have partnered to develop an immunotherapy to combat the COVID-19 coronavirus using the Ligand Antigen Epitope Presentation System (LEAPS) technology.